CAU
JNJ icon

Caxton Associates (UK)’s Johnson & Johnson JNJ Stock Holding History

Caxton Associates (UK)’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,016
Closed -$417K – 899
2025
Q4 		$417K Sell
2,016
-1,840
-48% -$364K 0.01% 544
2025
Q3 		$715K Sell
3,856
-817
-17% -$140K 0.02% 397
2025
Q2 		$714K Buy
+4,673
New +$718K 0.02% 363

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Caxton Associates (UK)'s JNJ Position: Q1 2026 in Review

Caxton Associates (UK) sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 2,016 shares — an estimated $417K sold.

Caxton Associates (UK) first reported a position in JNJ in Q2 2025 and held it in 3 quarters. The position peaked at $715K in Q3 2025. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Caxton Associates (UK) reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • Caxton Associates (UK) sold 2,016 Johnson & Johnson shares in Q1 2026, an estimated $417K.
  • Caxton Associates (UK) first reported a position in Johnson & Johnson in Q2 2025 and held it in 3 quarters.
  • Caxton Associates (UK)'s Johnson & Johnson position peaked at $715K in Q3 2025.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.